Hung‐Wei Wang

657 total citations
37 papers, 370 citations indexed

About

Hung‐Wei Wang is a scholar working on Epidemiology, Hepatology and Cancer Research. According to data from OpenAlex, Hung‐Wei Wang has authored 37 papers receiving a total of 370 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Epidemiology, 24 papers in Hepatology and 6 papers in Cancer Research. Recurrent topics in Hung‐Wei Wang's work include Liver Disease Diagnosis and Treatment (21 papers), Hepatitis C virus research (15 papers) and Hepatitis B Virus Studies (12 papers). Hung‐Wei Wang is often cited by papers focused on Liver Disease Diagnosis and Treatment (21 papers), Hepatitis C virus research (15 papers) and Hepatitis B Virus Studies (12 papers). Hung‐Wei Wang collaborates with scholars based in Taiwan, United States and China. Hung‐Wei Wang's co-authors include Cheng‐Yuan Peng, Wei‐Fan Hsu, Guan‐Tarn Huang, Hsueh‐Chou Lai, Wen‐Pang Su, Po‐Heng Chuang, Sheng‐Hung Chen, Chia‐Hsin Lin, Ting‐Yi Wang and Cheng‐Tang Chiu and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and Scientific Reports.

In The Last Decade

Hung‐Wei Wang

33 papers receiving 366 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hung‐Wei Wang Taiwan 12 235 207 56 41 34 37 370
P. Trande Italy 10 287 1.2× 260 1.3× 68 1.2× 79 1.9× 102 3.0× 16 469
Ibnauf Suliman United Kingdom 5 235 1.0× 272 1.3× 109 1.9× 23 0.6× 22 0.6× 5 437
Viktor Domislović Croatia 11 178 0.8× 84 0.4× 73 1.3× 26 0.6× 32 0.9× 45 308
Aaron Walfish United States 9 112 0.5× 102 0.5× 72 1.3× 17 0.4× 31 0.9× 46 249
D. Sforza Italy 12 94 0.4× 92 0.4× 123 2.2× 89 2.2× 39 1.1× 34 334
Nidah S. Khakoo United States 11 124 0.5× 110 0.5× 88 1.6× 35 0.9× 15 0.4× 20 371
Ángel Rubín Spain 15 379 1.6× 483 2.3× 269 4.8× 24 0.6× 22 0.6× 33 681
Giorgio Fusco Italy 9 282 1.2× 320 1.5× 125 2.2× 29 0.7× 29 0.9× 12 475
Alberto Luè Spain 9 91 0.4× 150 0.7× 124 2.2× 52 1.3× 18 0.5× 24 278
Aydın Dalgıç Türkiye 11 83 0.4× 172 0.8× 230 4.1× 34 0.8× 12 0.4× 62 407

Countries citing papers authored by Hung‐Wei Wang

Since Specialization
Citations

This map shows the geographic impact of Hung‐Wei Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hung‐Wei Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hung‐Wei Wang more than expected).

Fields of papers citing papers by Hung‐Wei Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hung‐Wei Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hung‐Wei Wang. The network helps show where Hung‐Wei Wang may publish in the future.

Co-authorship network of co-authors of Hung‐Wei Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Hung‐Wei Wang. A scholar is included among the top collaborators of Hung‐Wei Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hung‐Wei Wang. Hung‐Wei Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hsu, Wei‐Fan, Hsueh‐Chou Lai, Wen‐Pang Su, et al.. (2024). Trajectories and Decline of Serum Hepatitis B Surface Antigen Predict Outcomes in Patients With Chronic Hepatitis B. Open Forum Infectious Diseases. 11(12). ofae699–ofae699.
2.
Chen, Sheng‐Hung, Hsueh‐Chou Lai, Wen‐Pang Su, et al.. (2024). Liver stiffness and spleen stiffness predict distinct liver-related events after hepatitis C eradication with direct-acting antivirals. Journal of the Formosan Medical Association. 123(12). 1279–1286.
3.
Wang, Hung‐Wei, et al.. (2024). All-cause and cause-specific mortality risk among men and women with hepatitis C virus infection. PLoS ONE. 19(9). e0309819–e0309819.
4.
Wang, Hung‐Wei, Hsueh‐Chou Lai, Wen‐Pang Su, et al.. (2024). Real-world experience of lenvatinib-based therapy in patients with advanced hepatocellular carcinoma. Journal of Gastrointestinal Oncology. 15(5). 2216–2229.
5.
Hsu, Wei‐Fan, et al.. (2023). Adjuvant Sorafenib for Postoperative Patients with Hepatocellular Carcinoma and Macrovascular Invasion. Current Oncology. 30(12). 10134–10141. 1 indexed citations
6.
Chuang, Min‐Hsiang, et al.. (2023). Association between soluble α-klotho and mortality risk in middle-aged and older adults. Frontiers in Endocrinology. 14. 1246590–1246590. 12 indexed citations
7.
Wang, Hung‐Wei, Chi-Yi Chen, Hsueh‐Chou Lai, et al.. (2023). Prediction model of hepatocellular carcinoma in patients with hepatitis B virus-related compensated cirrhosis receiving antiviral therapy.. PubMed. 13(2). 526–537. 2 indexed citations
8.
Wang, Ting‐Yi, et al.. (2023). Prevalence of vitamin D deficiency and associated risk of all-cause and cause-specific mortality among middle-aged and older adults in the United States. Frontiers in Nutrition. 10. 1163737–1163737. 26 indexed citations
9.
Hsu, Wei‐Fan, Chien‐Hung Lin, Ying‐Chun Lin, et al.. (2022). Modified Albumin–Bilirubin Model for Stratifying Survival in Patients with Hepatocellular Carcinoma Receiving Anticancer Therapy. Cancers. 14(20). 5083–5083. 6 indexed citations
10.
Su, Yung‐Yeh, Jing‐Houng Wang, Hung‐Wei Wang, et al.. (2022). MO5-4 Potential roles of gut microbiome in patients with hepatocellular carcinoma treated with immune checkpoint inhibitors. Annals of Oncology. 33. S484–S484. 2 indexed citations
11.
Wang, Hung‐Wei, et al.. (2022). Association of dietary magnesium intake and glycohemoglobin with mortality risk in diabetic patients. PLoS ONE. 17(12). e0277180–e0277180. 6 indexed citations
12.
Chen, Yi-Chia, et al.. (2022). Association of hepatitis C virus infection status and genotype with kidney disease risk: A population-based cross-sectional study. PLoS ONE. 17(7). e0271197–e0271197. 3 indexed citations
13.
Wang, Hung‐Wei, Wen‐Pang Su, Wei‐Fan Hsu, et al.. (2021). On-Treatment Albumin-Bilirubin Grade: Predictor of Response and Outcome of Sorafenib-Regorafenib Sequential Therapy in Patients with Unresectable Hepatocellular Carcinoma. Cancers. 13(15). 3758–3758. 12 indexed citations
14.
Hsu, Wei‐Fan, Kai‐Chih Chang, Chien‐Hung Lin, et al.. (2021). Comparison of 10 noninvasive models for predicting overall survival in patients with intermediate-stage hepatocellular carcinoma. Medicine. 100(33). e27000–e27000. 4 indexed citations
15.
Wang, Hung‐Wei, et al.. (2021). Higher volume of water intake is associated with lower risk of albuminuria and chronic kidney disease. Medicine. 100(20). e26009–e26009. 10 indexed citations
16.
Hsu, Wei‐Fan, Hsueh‐Chou Lai, Wen‐Pang Su, et al.. (2019). Rapid decline of noninvasive fibrosis index values in patients with hepatitis C receiving treatment with direct-acting antiviral agents. BMC Gastroenterology. 19(1). 63–63. 45 indexed citations
17.
Chen, Sheng‐Hung, Hsueh‐Chou Lai, I‐Ping Chiang, et al.. (2018). Changes in liver stiffness measurement using acoustic radiation force impulse elastography after antiviral therapy in patients with chronic hepatitis C. PLoS ONE. 13(1). e0190455–e0190455. 22 indexed citations
18.
Wang, Hung‐Wei, et al.. (2017). New noninvasive index for predicting liver fibrosis in Asian patients with chronic viral hepatitis. Scientific Reports. 7(1). 3259–3259. 38 indexed citations
19.
Wang, Hung‐Wei, Chia‐Jung Kuo, Wey‐Ran Lin, et al.. (2016). Clinical Characteristics and Manifestation of Herpes Esophagitis. Medicine. 95(14). e3187–e3187. 11 indexed citations
20.
Kuo, Chia‐Jung, Kuang‐Hui Yu, Lai‐Chu See, et al.. (2015). The Trend of Inflammatory Bowel Diseases in Taiwan: A Population-Based Study. Digestive Diseases and Sciences. 60(8). 2454–2462. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by P. Trande Breakdown of academic impact, for papers by Ibnauf Suliman Breakdown of academic impact, for papers by Viktor Domislović Breakdown of academic impact, for papers by Aaron Walfish Breakdown of academic impact, for papers by D. Sforza Breakdown of academic impact, for papers by Nidah S. Khakoo Breakdown of academic impact, for papers by Ángel Rubín Breakdown of academic impact, for papers by Giorgio Fusco Breakdown of academic impact, for papers by Alberto Luè Breakdown of academic impact, for papers by Aydın Dalgıç
Rankless by CCL
2026